CBX2: A Potential Drug Target and Biomarker (G84733)

Target Name: CBX2

NCBI ID: G84733

CBX2

CBX2: A Potential Drug Target and Biomarker

Chromobox 2 (CBX2) is a gene that encodes a protein known to play a crucial role in the development and maintenance of tissues, particularly tissues that are involved in the formation of blood vessels. The study of CBX2 and its associated diseases has gained significant attention in recent years, with a growing body of research focusing on its potential as a drug target or biomarker.

CBX2 and its function

CBX2 is a single-chain protein that contains 251 amino acid residues. It is characterized by a N-terminal transmembrane domain, a catalytic domain, and a C-terminal T-loop domain. The N-terminal transmembrane domain is responsible for the protein's ability to interact with various cell surface molecules, while the catalytic domain is responsible for its catalytic activity. The C-terminal T-loop domain is involved in the regulation of protein stability and functions.

One of the most significant functions of CBX2 is its role in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to tissues. CBX2 has been shown to play a critical role in the formation of new blood vessels in various tissues, including the brain and the heart.

In addition to its role in angiogenesis, CBX2 has also been shown to play a significant role in the regulation of cell signaling pathways. CBX2 has been shown to interact with various signaling molecules, including TGF-β, PDGF, and Wnt. These interactions have been shown to play a critical role in the regulation of cell proliferation, migration, and survival.

CBX2 as a drug target

CBX2's unique function and its potential as a drug target have made it an attractive target for researchers to explore. Several studies have shown that CBX2 can be effectively targeted by small molecules, such as inhibitors or activators. These small molecules have been shown to have a significant impact on the functions of CBX2, including its ability to regulate angiogenesis and cell signaling pathways.

One of the most promising strategies for targeting CBX2 is the use of small molecules that can inhibit its catalytic activity. These inhibitors have been shown to have a significant impact on the functions of CBX2, including its ability to regulate angiogenesis and cell signaling pathways.

Another approach to targeting CBX2 is the use of small molecules that can activate its catalytic activity. These activators have been shown to have a significant impact on the functions of CBX2, including its ability to regulate angiogenesis and cell signaling pathways.

CBX2 as a biomarker

CBX2 has also been shown to be a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This is because its functions as a protein are involved in the regulation of many different processes that are involved in the development and progression of these diseases.

For example, CBX2 has been shown to play a critical role in the regulation of angiogenesis, which is a process that is involved in the formation of new blood vessels. The development of new blood vessels is a key factor in the progression of many diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

In addition to its role in angiogenesis, CBX2 has also been shown to play a significant role in the regulation of cell signaling pathways. The functions of CBX2 as a protein are involved in the regulation of many different signaling pathways, including those that are involved in the development and progression of cancer, neurodegenerative diseases, and cardiovascular diseases.

Conclusion

CBX2 is a protein that has been shown to play a

Protein Name: Chromobox 2

Functions: Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development (PubMed:21282530). PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:21282530). Binds to histone H3 trimethylated at 'Lys-9' (H3K9me3) or at 'Lys-27' (H3K27me3) (By similarity). Plays a role in the lineage differentiation of the germ layers in embryonic development (By similarity). Involved in sexual development, acting as activator of NR5A1 expression (PubMed:19361780)

The "CBX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CBX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets